Fungal infections with a particular focus on the compromised host.
D000196:Actinomycosis / Q000276:immunology; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000276:immunology; D002177:Candidiasis / Q000276:immunology; D002648:Child; D003453:Cryptococcosis / Q000276:immunology; D003881:Dermatomycoses / Q000276:immunology; D005260:Female; D005658:Fungi; D006660:Histoplasmosis / Q000276:immunology; D006801:Humans; D007154:Immune System Diseases / Q000150:complications*; D007166:Immunosuppressive Agents / Q000009:adverse effects; D009181:Mycoses / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D009617:Nocardia Infections / Q000276:immunology
D000935:Antifungal Agents; D007166:Immunosuppressive Agents